K-numberK243296
Device nameDisposable Biopsy Needle
ApplicantCarbon (Shenzhen) Medical Device Co., Ltd.
Product codeKNW
Device classClass II
Decision dateJul 11, 2025
DecisionSubstantially Equivalent
Regulation876.1075
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Disposable Biopsy Needle is a sterile, single-use, spring-loaded percutaneous biopsy instrument intended for obtaining soft tissue samples from organs such as liver, kidney, and prostate under ultrasound guidance. It consists of a cannula, inner stylet, mechanical power device, and protective cover, and is not intended for bone biopsy.

Technological characteristics

The subject device is an 18-gauge biopsy needle available in 100mm, 150mm, and 200mm lengths with a 21mm penetration depth and 18mm sample notch. It uses spring-operated mechanics, ethylene oxide sterilization at 10⁻⁶ SAL, and includes materials such as stainless steel cannula/stylet, polydimethylsiloxane fluid, POM, ABS, and polypropylene. It has a 2-year shelf life and includes a locking safety feature.

Test standards cited

ISO 10993 series (Parts 5, 10, 23, 11, 4) for biocompatibility; ISO 11135 and ISO 10993-7 for sterilization and ethylene oxide residuals; ISO 9626, ISO 7864, and ISO 6009 for needle specifications; ASTM standards (F1886, F1929, F88, F1980, D4169, F756) for packaging and seal integrity; USP tests for pyrogen and sterility; and DIN 58953-6 for microbial barrier testing.

Substantial equivalence argument

The subject device is substantially equivalent because it shares the same intended use (soft tissue biopsy), same regulatory classification (Class II, 21 CFR 876.1075, Product Code KNW), identical spring-operated mechanism, and comparable performance characteristics to the predicate Bard Max-Core device. While the subject device covers only 18-gauge specification versus the predicate's 14G-20G range and uses ultrasound-only visualization versus the predicate's multiple modalities, these are restrictions rather than expansions of intended use. Non-clinical testing demonstrates biocompatibility, sterilization effectiveness, packaging integrity, and sampling performance matching the predicate, with documented testing confirming the safety lock function and tissue sampling capability across porcine and canine tissues.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →